Tkg Advisors, LLC Abb Vie Inc. Transaction History

Tkg Advisors, LLC

  • $197 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 23, 2024
SELL
$137.6 - $154.97 $550 - $619
-4 Reduced 0.25%
1,592 $246,000
Q3 2023

Nov 02, 2023
BUY
$133.59 - $154.65 $213,209 - $246,821
1,596 New
1,596 $237,000
Q1 2023

Apr 19, 2023
BUY
$144.61 - $166.54 $607,651 - $699,801
4,202 New
4,202 $669,000

Others Institutions Holding ABBV

# of Institutions
3,853
Shares Held
1.25B
Call Options Held
16.8M
Put Options Held
12.2M
View Full List

About AbbVie Inc.

ABBV Quotes by TradingView
  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Tkg Advisors, LLC Portfolio

Follow Tkg Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tkg Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tkg Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email